Institutional investors hold a majority ownership of TMO through the 89.34% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2017, these large investors purchased a net $1.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE TEACHERS RETIREMENT SYSTEM... Bought 96.3 Thousand shares of Thermo Fisher Scientific ...